Worked example · 03

Recovery can matter without becoming a price

What does a private Non-Performance observation produce?

Morning · recovery

A redacted recovery period becomes meaningful because repeated synthetic checks indicate improved recovery under the required evidence format.

This is a synthetic variation on the paper’s redacted public worked day. It teaches a branch of the model; it is not a private record, observed personal event or empirical finding.

World 01 / 03

Human State Atlas

Physiology · private state route

See the related cases

Short answer

A represented state update—not an economic value claim.

01 · Moment

Observed time slice

A bounded event with context and provenance.

02 · Economic question

No economic route

No typed VC output is constituted here.

03 · Human question

+0.014 WellbeingScore movement

Wbefore 700.000 → Wafter 700.014

One event can produce two independently governed answers. Orange marks an active result; graphite preserves an inactive or unavailable possibility without turning it into zero.

Show the calculation

Four questions, in order.

  1. 01

    Start with the prior state

    The event reads Wbefore = 700.000.

  2. 02

    Ask the economic question

    No typed Vcom is constituted for this case.

  3. 03

    Ask the human-state question

    The reviewed input produces deltaW = 0.014, so Wafter = 700.014.

  4. 04

    Keep the units honest

    No economic VC output is produced. A wellbeing movement is not converted into money or credits.

What this means

The eligible observation may change Wafter and deltaW in WellbeingScore units while Vcom and VC remain inapplicable.

What it does not mean

This is not a diagnosis, a price for rest or evidence that recovery caused a particular future outcome.

Technical layerAudit the calculationInspect statuses, intermediate values, provenance, uncertainty and raw scenario structure.
Source settlement
not applicable
Impact review
applied
Replay eligibility
eligible
Valuation
not applicable nonperformance
Projection
canonical
Wbefore
700.000
Component delta
0.07
deltaW
0.014
Wafter
700.014
Vcom_event
null
VCperformance_event
null

Pinned implementation calculation

Complete component-transition trace

Every input and intermediate value is carried by the stable synthetic fixture or derived from its pinned issuer-policy snapshot.

Components before
{ "Physiology": 700, "Emotion": 700, "Feeling": 700, "Thought": 700, "Habit": 700, "Performance": 700 }
calculated_Wbefore
700
Affected component
Physiology
component_before
700
Band
(600,700]
band_rate
0.03
adjustment_factor
0.005
Direction
positive
Intensity
medium
intensity_multiplier
2/3
maximum_move
0.105
calculated_component_delta
0.07
component_after
700.07
component_weight
0.2
calculated_deltaW
0.014
calculated_Wafter
700.014
Typed Vcom_event
null
Typed VCperformance_event
null

maximum_move = 700 × 0.03 × 0.005 = 0.105

component_delta = 0.105 × 2/3 × 1 = 0.07

component_after = 700 + (0.07) = 700.07

deltaW = 0.07 × 0.2 = 0.014

Wafter = 700 + (0.014) = 700.014

Required case note

Impact justification

Assumed synthetic evidence
A synthetic owner observation records improved recovery on repeated checks and includes the evidence fields required by the community policy.
Reviewed decision input
positive · medium
Calculation demonstrated
The calculator applies the pinned HouseOfBros Founder Policy v0.1 transition matrix to the declared component state. It does not infer direction or intensity from the evidence narrative.
Decision rationale
Medium positive demonstrates a bounded Physiology transition; it is not a diagnosis or economic value claim.
Alternative interpretations
  • Confounding could support no_transition.
  • Insufficient evidence could remain pending.
Uncertainty
This synthetic case has not been calibrated against observed longitudinal evidence or independent reviewer agreement.
Evidence-to-intensity rubric
unvalidated. Direction and intensity are reviewed inputs; the calculator does not infer them from prose.
Validation research required
Repeated measures, evidence-quality criteria, clinical-safety review and independent reviewer agreement.